RESONANCE share price, P/E, ROE & financials

Resonance Specialties (BSE: RESONANCE) had a P/E of 18.1× on 6 Nov 2026, below the industry P/E of 18.2×. It earns ROCE of 19% and ROE of 28%, and sales and net profit grew 15% and 28% a year over 3 years. It has almost no debt, and its dividend yield is 0.4%. It is a small-cap company with a market cap of ₹263 Cr, ranked 48th of 76 Chemicals companies by market cap; the shares rose 141% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹229.00
Day high: ₹231.00
Day low: ₹224.00
Prev. close: ₹229.15
Volume: 20K

Health check

4 good · 2 fair

ReturnsAhead
+141.5% over a year, better than 7 of 7 peers.
Price tagIn line
P/E 18.1 vs industry 18.2.
GrowthStrong
Sales +15.2%, profit +27.6% a year over 3 years.
ProfitabilityAverage
ROCE 18.8% vs peer median 10.6%.
Balance sheetSolid
Practically debt-free, Piotroski 6 of 9.
Red flagsNone found
No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Chemicals

75 listed peers. Screen the industry

Small cap

₹263 Cr, #48 of 76 in its industry by size.

Defensive

Beta 0.46 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹114 Cr · profit ₹21 Cr

Market cap: ₹263 Cr; Small cap
P/E: 18.1; Industry 18.2
Price to book: 3.05; Peers 2.62
Dividend yield: 0.44%
ROE: 28.0%; Peers 11.7%
ROCE: 18.8%; Peers 10.6%
Debt to equity: 0.00; Debt ₹0.16 Cr
EPS (TTM): ₹12.58
OPM (TTM): 18.6%; Net margin 18.7%
Sales growth: +53.2%; Latest quarter vs a year ago
Profit growth: +252.3%; Latest quarter vs a year ago
Price to sales: 2.30; EV/EBITDA 8.9

Strengths

Return on equity of 28.0%.
Practically debt-free.
Quarterly profit up 252.3% on a year ago.
Quarterly sales up 53.2% on a year ago.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in agrochemicals, pharmaceuticals, latexes, food, and allied industries, as well as to manufacture vitamins, medicines, food flavoring, dyes, adhesives, pesticides, herbicides, etc.; and picolines, including beta and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and…

Headquarters: Mumbai
Employees: 74
Sector: Basic Materials
ISIN: INE486D01017
Website: resonancesl.com

Price range

52 weeks

₹77.00₹248.00

Today

₹224.00₹231.00

Avg volume (3M): 32.1K
1-year return: plus 141.5%
From 52-week high: minus 8.1%

Peers · Chemicals

Capital-heavy industry columns

Compare with peers Screen the whole industry

Company
NAVINFLUORNavin Fluorine International	9,010.00	plus 1.87%	46,250	50.8	42.7	18.7%	34.3%	0.28	16.5%	plus 46.1%
DEEPAKNTRDeepak Nitrite	1,533.60	minus 0.67%	20,917	19.7	22.3	10.8%	18.0%	0.27	−0.5%	minus 11.9%
TATACHEMTata Chemicals	607.45	minus 1.36%	15,475	–	12.4	−3.0%	12.2%	0.36	−4.8%	minus 31.0%
DEEPAKFERTDeepak Fertilisers & Petrochemicals Corp.	1,155.30	minus 0.69%	14,599	14.8	11.5	11.2%	17.6%	0.76	2.6%	minus 22.7%
RPELRaghav Productivity Enhancers	1,780.80	plus 0.95%	8,178	116.0	107.1	–	29.9%	0.02	23.5%	plus 95.4%
GNFCGujarat Narmada Valley Fertilizers and Chemicals	451.80	minus 1.87%	6,639	6.3	5.4	10.4%	14.8%	0.01	−8.8%	minus 7.2%
ACIArchean Chemical Industries	416.40	minus 1.95%	5,141	51.3	23.2	7.7%	20.0%	0.28	−9.2%	minus 34.6%
RESONANCEResonance Specialties	227.80	minus 0.59%	263	18.1	17.9	18.8%	18.6%	0.00	15.2%	plus 141.5%
Median of 7 peers	–	−0.69%	14,599	35.2	22.3	10.6%	18.0%	0.28	−0.5%	−11.9%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
21.3	21.5	23	24.5	32.6
18.7	19.2	19.5	18.8	25.1
2.6	2.4	3.5	5.6	7.5
12.0%	11.0%	15.0%	23.1%	22.9%
0.2	0.4	0.3	0.7	0.5
0.1	0.1	0.1	0	0
0.3	0.3	0.3	0.3	0.3
2.4	2.3	3.4	6	7.6
31.3%	28.8%	25.7%	23.3%	24.9%
1.6	1.7	2.5	4.6	5.7
1.41	1.44	2.18	3.98	4.98

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +15.2%
Profit CAGR 3Y: +27.6%
EPS CAGR 3Y: +27.6%
ROE: 28.0%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
58.3	54.7	77.1	89.2
–	minus 6.2%	+41.0%	+15.7%
51.5	49.9	66.3	75.1
6.8	4.8	10.8	14.1
11.7%	8.8%	14.1%	15.8%
1.5	0.9	0.6	1.3
0	0.3	0.3	0.2
1.5	1.5	1.6	1.3
0	0	−0.7	0.2
6.9	4	8.9	14.1
27.0%	25.1%	26.0%	26.1%
5	3	6.6	10.4
–	minus 40.6%	+121.2%	+58.3%
4.33	2.56	5.69	9.01

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
11.5	11.5	11.5	11.5
44.1	46	52.5	61.7
2.3	4.2	3.3	2.2
7.8	12.1	8.2	17
65.8	73.8	75.6	92.5
19.7	22.1	20.9	23.4
0.4	0.3	0.6	3.7
0.7	0.7	0.7	0.7
3.9	4.6	0.2	11.8
41	46	53.2	53
65.8	73.8	75.6	92.5

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
−8.4	4.2	−2.5	17.3
3.2	−6.6	3.6	−14.9
0.9	0.3	−1.2	−2.5
−4.2	−2.1	−0.2	−0
−7.6	−4.4	−1.2	−3.7
−16	−0.3	−3.7	13.6
−1.2	−1.2	–	−1.2

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you